No, an anaplastic oligodendroglioma (WHO Grade 3) is NOT a form of glioblastoma.
Anaplastic oligodendroglioma and glioblastoma are distinct tumor entities with different molecular profiles, prognoses, and treatment approaches. These are separate branches in the modern classification of diffuse gliomas.
Key Distinguishing Features
Molecular Definition
According to current WHO classification, oligodendrogliomas are defined by:
In contrast, glioblastomas are:
- IDH wild-type in >90% of cases
- Lack 1p/19q co-deletion
- Harbor EGFR amplification, TERT promoter mutations, and/or +7/-10 cytogenetic signature 1
Critical Nomenclature Change
The term "glioblastoma" is now reserved exclusively for IDH-wild-type tumors 1. Even when IDH-mutant astrocytomas (not oligodendrogliomas) reach WHO grade 4 with necrosis or microvascular proliferation, they are now called "astrocytoma, IDH-mutant, WHO grade 4" rather than "glioblastoma" because they are biologically distinct entities despite similar histological appearance 1.
Why This Distinction Matters Clinically
Prognosis
- Oligodendrogliomas (including anaplastic/grade 3): Significantly better prognosis with median survival measured in years to over a decade
- Glioblastoma (IDH wild-type, grade 4): Poor prognosis with median survival of 15-18 months despite aggressive treatment
Treatment Differences
Anaplastic oligodendroglioma 1:
- Radiotherapy (54-60 Gy) followed by PCV chemotherapy
- Highly chemosensitive tumors
- Temozolomide at progression
Glioblastoma 1:
- Temozolomide chemoradiotherapy (concurrent and adjuvant)
- Less chemosensitive
- Different salvage options including bevacizumab
Common Pitfall to Avoid
Do not confuse historical terminology with current classification. Before 2016, some mixed gliomas with necrosis were called "anaplastic oligoastrocytoma" or even misclassified. The 1p/19q co-deletion status is the definitive branch point that separates oligodendroglial tumors from astrocytic tumors (including glioblastoma) 2. Without 1p/19q co-deletion, a tumor cannot be an oligodendroglioma regardless of histological appearance.
The molecular profile determines the diagnosis, not just the histological grade. An anaplastic oligodendroglioma remains fundamentally an oligodendroglioma—a distinct entity from glioblastoma with different biology, behavior, and treatment response 3.